Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Mast cells in atopic dermatitis.

Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y.

Curr Opin Immunol. 2009 Dec;21(6):666-78. doi: 10.1016/j.coi.2009.09.006. Epub 2009 Oct 14. Review.

2.

Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice.

Abboud G, Staumont-Sallé D, Kanda A, Roumier T, Deruytter N, Lavogiez C, Fleury S, Rémy P, Papin JP, Capron M, Dombrowicz D.

J Immunol. 2009 May 15;182(10):6517-26. doi: 10.4049/jimmunol.0801055.

3.

IgE-mediated, Fc(epsilon)RI-dependent allergen presentation: a pathogenetic factor in atopic dermatitis?

Stingl G.

J Am Acad Dermatol. 2001 Jul;45(1 Suppl):S17-20. No abstract available.

PMID:
11423866
4.

Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis.

Novak N, Bieber T, Kraft S.

Curr Allergy Asthma Rep. 2004 Jul;4(4):263-9. Review.

PMID:
15175139
5.

Mast cells and basophils in acquired immunity.

Wedemeyer J, Galli SJ.

Br Med Bull. 2000;56(4):936-55. Review.

PMID:
11359630
6.

Polyclonal IgE induces mast cell survival and cytokine production.

Kashiwakura J, Kawakami Y, Yuki K, Zajonc DM, Hasegawa S, Tomimori Y, Caplan B, Saito H, Furue M, Oettgen HC, Okayama Y, Kawakami T.

Allergol Int. 2009 Sep;58(3):411-9. doi: 10.2332/allergolint.08-OA-0080. Epub 2009 Jun 25.

7.

A human monoclonal IgE antibody that binds to MGL_1304, a major allergen in human sweat, without activation of mast cells and basophils.

Ishii K, Hiragun M, Hiragun T, Kan T, Kawaguchi T, Yanase Y, Tanaka A, Takahagi S, Hide M.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):99-104. doi: 10.1016/j.bbrc.2015.10.154. Epub 2015 Nov 2.

PMID:
26541454
8.
9.

Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor.

Cox HE, Moffatt MF, Faux JA, Walley AJ, Coleman R, Trembath RC, Cookson WO, Harper JI.

Br J Dermatol. 1998 Jan;138(1):182-7.

PMID:
9536245
10.

IgE, mast cells, and eosinophils in atopic dermatitis.

Liu FT, Goodarzi H, Chen HY.

Clin Rev Allergy Immunol. 2011 Dec;41(3):298-310. doi: 10.1007/s12016-011-8252-4. Review.

PMID:
21249468
11.

Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone.

Yamaguchi M, Hirai K, Komiya A, Miyamasu M, Furumoto Y, Teshima R, Ohta K, Morita Y, Galli SJ, Ra C, Yamamoto K.

Int Immunol. 2001 Jul;13(7):843-51.

PMID:
11431414
12.

[IgE receptors in Langerhans cells. A link between the environment and the immune system?].

Bieber T.

Hautarzt. 1992 Dec;43(12):753-62. Review. German.

PMID:
1473969
14.

Molecular aspects of allergy.

Miescher SM, Vogel M.

Mol Aspects Med. 2002 Dec;23(6):413-62. Review.

PMID:
12385747
15.

Surface expression of Fc epsilon RI on Langerhans' cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis.

Semper AE, Heron K, Woollard AC, Kochan JP, Friedmann PS, Church MK, Reischl IG.

J Allergy Clin Immunol. 2003 Aug;112(2):411-9.

PMID:
12897750
17.

Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI.

Jürgens M, Wollenberg A, Hanau D, de la Salle H, Bieber T.

J Immunol. 1995 Dec 1;155(11):5184-9.

PMID:
7594528
18.

Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells.

Rajakulasingam K, Durham SR, O'Brien F, Humbert M, Barata LT, Reece L, Kay AB, Grant JA.

J Allergy Clin Immunol. 1997 Jul;100(1):78-86.

PMID:
9257791
19.

IgE and Fc{epsilon}RI regulation.

Macglashan D Jr.

Ann N Y Acad Sci. 2005 Jun;1050:73-88. Review.

PMID:
16014522
20.

Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions.

Fung-Leung WP, De Sousa-Hitzler J, Ishaque A, Zhou L, Pang J, Ngo K, Panakos JA, Chourmouzis E, Liu FT, Lau CY.

J Exp Med. 1996 Jan 1;183(1):49-56.

Supplemental Content

Support Center